soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025

soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Reduces Events in People with Type 2 soul trial oral semaglutide cardiovascular

Name: soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Reduces Events in People with Type 2 soul trial oral semaglutide cardiovascular
Brand: bedrijvenverenigingharen.nl
SKU: 8208032741
Price: 22.32 USD
Availability: InStock
Rating: 4.6525 (8 reviews)

SKU: 8208032741

4.7

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

p=0.001)

Specifically, tirzepatide was associated with a 50% reduced risk of POAG, 26% reduced risk of OHT and 41% reduced risk of requiring new glaucoma treatment